8
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Metabolism of the aminoterminal propeptide of type III procollagen in cultures of human proximal tubular cells

, , , &
Pages 1-8 | Received 12 Apr 1991, Accepted 17 Jul 1991, Published online: 08 Jul 2009

References

  • Risteli L, Risteli J. Non-invasive methods for detection of organ fibrosis. Focus on Connective Tissue in Health and Disease, M Rojkind. CRC Press Inc., Boca Raton, Florida 1990; Vol. 1: 61–98
  • Niemelii O, Risteli L, Sontaniemi E A, Risteli J. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum. Clin Chim Acta 1982; 124: 39–44
  • Bentsen K D, Henriksen J H, Boesby S, Hørslev-Petersen K, Lorenzen I. Hepatic and renal extraction of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig. J Hepatol 1989; 9: 177–83
  • Smedsrød B. Aminoterminal propeptide of type ill procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Coll Rel Res 1988; 8: 375–88
  • Rucklidge G J, Milne G, Riddoch G I, Rohins S P. Evidence for renal tubular resorption of collagen fragments from immunostaining of rat kidney with antibiodies specific for denatured type I collagen. Coll Rel Res 1986; 6: 185–93
  • Rucklidge G J, Riddoch G I, Williams L M, Robins S P. Autoradiographic studies of the renal clearance of circulating type I collagen fragments in the rat. Coll Rel Res 1988; 8: 339–48
  • Blaehr H, Friis S. Acute inhibition of human renal tubular cell growth by cyclosporin A. Pharmacol Toxicol 1990; 66: 115–20
  • Blaehr H. Human renal biopsies as source of cells for glomerular and tubular cell cultures. Scand J Urol Nephrol 1991; 25: 287–95
  • Niemelii O, Risteli L, Parkkinen J, Risteli J. Purification and characterization of the N-terminal propeptide of human type III procollagen. Biochem J 1985; 232: 145–50
  • Salacinski P RP, McLean C, Sykes J EC, Clement-Jones V V, Lowry P J. Inclination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1, 3, 4, 6-tetrachloro-3α, 6α-diphenyl glucouril (iodogen). Anal Biochem 1981; 117: 136–46
  • Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat A P, Risteli L. Rapid equilibrium radio-immunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–8
  • Rohde H, Langer I, Krieg T, Timpl R. Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments. Coll Rel Res 1983; 3: 371–9
  • Hørslev-Petersen K, Bentsen K, Junker P, Lorenzen I. Serum aminoterminal type III procollagen peptide in rheumatoid arthritis. Arthritis Rheum 1986; 29: 592–9
  • Blaehr H, Andersen C B, Ladefoged J. Release and effect of prostaglandin E2 of human tubular cells in cultures. J Clin Lab Imm 1990; 31: 137–43
  • Rahe A F. Tables of critical values for the Pratt matched pair signed rank statistics. J Am Stat Assoc 1974; 69: 368–73
  • Maunsback A B. Absorption of I125-labeled homologous albumin by rat kidney proximal tubule cells. J Ultrastruct Res 1955; 15: 197–241
  • Striker G E, Killen P D, Farin F M. Human glomerular cells in vitro: isolation and characterization. Transplantation Proceedings 1980; 12((3)(Suppl 1))88–99
  • Bowness J M, Folks J E, Timpl R. Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J Biol Chem 1987; 262: 1022–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.